Search

Your search keyword '"Baras, Alexander"' showing total 521 results

Search Constraints

Start Over You searched for: Author "Baras, Alexander" Remove constraint Author: "Baras, Alexander"
521 results on '"Baras, Alexander"'

Search Results

1. Multimodal Prototyping for cancer survival prediction

2. AMIGO: Sparse Multi-Modal Graph Transformer with Shared-Context Processing for Representation Learning of Giga-pixel Images

4. Analysis of 3D pathology samples using weakly supervised AI

6. Integrative Tumor and Immune Cell Multi-omic Analyses Predict Response to Immune Checkpoint Blockade in Melanoma.

7. Weakly Supervised Prostate TMA Classification via Graph Convolutional Networks

8. Deep Adversarial Training for Multi-Organ Nuclei Segmentation in Histopathology Images

9. The Journey to Improve the College of American Pathologists Cancer Biomarker Reporting Protocols.

10. Computational methods and biomarker discovery strategies for spatial proteomics: a review in immuno-oncology.

19. Multimodal genomic features predict outcome of immune checkpoint blockade in non-small-cell lung cancer

21. 1511 Pan-tumor harmonization of pathologic response assessment for standardized data collection in neoadjuvant IO trials (PATHdata): Interim analysis of a multi-institutional reproducibility study

23. Cost Effectiveness of Intraoperative Gross Examination in Colorectal Resections: A Retrospective Review of 200 Consecutive Cases

28. Reporting Practices and Resource Utilization in the Era of Intraductal Carcinoma of the Prostate: A Survey of Genitourinary Subspecialists

30. Data from Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery

31. Supplementary Data from Spatial UMAP and Image Cytometry for Topographic Immuno-oncology Biomarker Discovery

32. Supplementary Figure 1 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

33. Data from AACR Project GENIE: Powering Precision Medicine through an International Consortium

34. Table S3 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

35. Supp Figure 4 from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

36. Supp Figure 1 from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

37. Supp Figure 3 from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

38. Supp Figure legends from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

39. Supp Figure 3 continued from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

40. Supplemental Methods, Supplemental Tables 1-2, Supplemental Figures 1-4 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

41. Supplemental File 1 from AACR Project GENIE: Powering Precision Medicine through an International Consortium

42. Supp Figure 2A from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

43. Tables S1-S7 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

44. Supp Table 1, Supp Table 2 from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

45. Data from Involvement of Epigenetics and EMT-Related miRNA in Arsenic-Induced Neoplastic Transformation and Their Potential Clinical Use

46. Data from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

47. Supplementary Data 2 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

48. Supplementary Data 1 from The Mutation-Associated Neoantigen Functional Expansion of Specific T Cells (MANAFEST) Assay: A Sensitive Platform for Monitoring Antitumor Immunity

49. Supplementary Data from Genomic Landscapes and Hallmarks of Mutant RAS in Human Cancers

50. Supplementary Data from Adaptive Immune Resistance to Intravesical BCG in Non–Muscle Invasive Bladder Cancer: Implications for Prospective BCG-Unresponsive Trials

Catalog

Books, media, physical & digital resources